Michelle A. Peluso - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP and Co-President of Retail
Signature: /s/ Michelle A. Peluso
Issuer symbol: CVS
Transactions as of: 01 Apr 2022
Net transactions value: +$5,779,517
Form type: 4
Filing time: 05 Apr 2022, 19:41:54 UTC
Previous filing: 01 Mar 2022
Next filing: 13 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVS	Common Stock						14,911	01 Apr 2022	Direct
holding	CVS	Common Stock (restricted)						82,563	01 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$5,779,517	+57,172		$101.09	57,172	01 Apr 2022	Common Stock	57,172	$101.09	Direct	F2
holding	CVS	Stock Option						86,386	01 Apr 2022	Common Stock	86,386	$74.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
F2	Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
F3	Option becomes exercisable in four equal annual installments, commencing 4/1/2022.